Button to scroll to the top of the page.

Jonathan Sessler, who was recently named UT Austin's Inventor of the Year, is well known for his innovative contributions, which have spanned several decades on this campus. A cancer survivor himself, he developed a class of molecules, texaphyrins, that hold promise to treat future cancer patients. Together with the doctor who helped him recover from lymphoma, Dr. Sessler co-founded a company, Pharmacyclics, which later was responsible for a new blockbuster drug for blood cancer. 

Dr. Sessler is an excellent example of the entrepreneurial spirit and world-changing abilities of our UT Austin chemists. That spirit is one reason that The University of Texas at Austin ranks 13th worldwide for chemistry in U.S. News and World Report's most recent Best Global Universities rankings. Watch the video below about Dr. Sessler and read more about his work, and other news of the department in our newsletters, which we share with supporters who make us a science education leader and a hub for discovery and innovation that changes the world.


Continue to the Fall 2016 newsletter.



Spring 2016 Fall 2008 Spring 2000
Fall 2015 Fall 2007 Fall 1999
Spring 2015 Spring 2006 Spring 1999
Fall 2014 Fall 2005 Fall 1998
Spring 2014 Fall 2003 Spring 1998
Fall 2013 Spring 2003 Fall 1997
Spring 2013 Spring 2002 Spring 1997
Fall 2011 Fall 2001 Fall 1996
Spring 2010 Spring 2001 Spring 1996
Spring 2009 Fall 2000 Fall 1995